Recommendations

Key recommendations for advancing integrated AMR and AMU surveillance in the Nordic region, based on the Roadmap.

1. Address Data Granularity

  • Start with nationally aggregated, standardised, de-identified datasets to avoid GDPR complications
  • Develop a regulatory framework enabling access to both aggregated summaries and raw anonymised data
  • Establish a joint secure platform for collected data
  • See Reporting of Aggregated Data

2. Preserve Raw Quantitative Data

  • Store raw MIC and disk zone diameter data (not just S/I/R classifications)
  • Enable retrospective analysis when EUCAST breakpoints change
  • See AST Reporting

3. Connect Laboratory and Clinical Data

  • Build secure systems linking bacterial isolates to patient diagnoses
  • Leverage electronic medical records and health data registries
  • Use unique patient identifiers with privacy protections
  • Adopt standardised data formats (e.g., WHO GLASS-compatible frameworks)
  • See Clinical Isolate-Diagnosis Link

4. Enable Real-Time Sharing

  • Develop near real-time data sharing for high-priority pathogen/drug combinations
  • Build on existing national notification systems for selected resistant phenotypes
  • See Real-Time Data Sharing

5. Address Sampling Bias

  • Sample both healthy and sick individuals across human, animal, and environmental sectors
  • Monitor sewage as a composite sample of the entire population of a city
  • Extend surveillance beyond clinical settings to include community-based sampling
  • See Sampling Bias

6. Address Secondary Data Use Barriers

  • Develop cross-border data-sharing frameworks compliant with GDPR
  • Establish joint secure computing environments for sensitive data
  • Address legal restrictions on secondary use of data across national borders
  • Explore federated machine learning for joint analyses on data that cannot be directly shared
  • See Legal and Ethical Considerations